Artiva’s AlloNK Study for Scleroderma

Artiva's AlloNK® Study for scleroderma aims to understand whether an investigational natural killer (NK) cell therapy can help reduce your scleroderma symptoms.

Artiva’s AlloNK Study for Refractory Rheumatoid Arthritis

Artiva's AlloNK® Study for refractory rheumatoid arthritis aims to understand whether an investigational natural killer (NK) cell therapy can help reduce your rheumatoid arthritis symptoms.

Osteogenesis Imperfecta (OI) | Clinical Study

A clinical study for children and adolescents with osteogenesis imperfecta (OI). If your child or a loved one has OI, they may be eligible for this study, which is evaluating if an investigational medication, romosozumab, may be a potential therapy for osteogenesis imperfecta.

Artiva’s AlloNK Study for Sjögren’s

Artiva's AlloNK® Study for Sjögren’s aims to reduce inflammation and symptoms of Sjögren’s.

ZuraBio | TibuSURE | Systemic Sclerosis Study

If you or a loved one are living with systemic sclerosis (scleroderma or SSc), consider joining the TibuSURE clinical study where researchers are exploring whether a new study drug could impact disease progression in individuals with systemic sclerosis.

SENTRY-CD19 | Leukemia and Lymphoma Clinical Study

If you or a loved one has leukemia or lymphoma, learn more about this opportunity to participate in a clinical study evaluating a one-time investigational gene therapy that may help your immune system fight cancer more effectively.

Artiva’s AlloNK Study for Myositis

Artiva's AlloNK® Study for myositis aims to reduce inflammation and symptoms of Polymyositis (PM),Dermatomyositis (DM), or Inclusion Body Myositis (IBM).

X-TOLE and X-ACKT | Epilepsy Studies

For those living with either focal-onset seizures (FOS) or primary generalized tonic-clonic seizures (PGTCS), you may be eligible for a clinical trial that may help reduce the frequency of seizures.

Sjögren’s Clinical Study

If you have Sjögren’s, you may be eligible to participate in a clinical study looking to help relieve symptoms related to Sjögren’s and evaluate changes in your quality of life.

Interstitial Cystitis/Bladder Pain Syndrome Clinical Study

Is pelvic pain an issue for you? You may be eligible to participate in a clinical trial for an alternative treatment.

Resolve Sjögren’s Clinical Study

If you have Sjögren’s, you may be eligible for the Resolve Sjögren’s study, which is evaluating if a study drug may reduce fatigue, dryness in the eyes and mouth, and joint pain in women with Sjögren’s.